PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?

This is the protocol for a Campbell review. The objectives are as follows: One goal of this systematic review is to identify whether incentive terms in CEO contracts predict firm financial performance over time; a second goal is to identify whether incentive terms in CEO contracts predict subsequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Rousseau, Denise M., Beck, Donna, Kim, ByeongJo, Splenda, Ryan, Young, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
PROTOCOL
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356531/
https://www.ncbi.nlm.nih.gov/pubmed/37131856
http://dx.doi.org/10.1002/cl2.1064
_version_ 1783736964261871616
author Rousseau, Denise M.
Beck, Donna
Kim, ByeongJo
Splenda, Ryan
Young, Sarah
author_facet Rousseau, Denise M.
Beck, Donna
Kim, ByeongJo
Splenda, Ryan
Young, Sarah
author_sort Rousseau, Denise M.
collection PubMed
description This is the protocol for a Campbell review. The objectives are as follows: One goal of this systematic review is to identify whether incentive terms in CEO contracts predict firm financial performance over time; a second goal is to identify whether incentive terms in CEO contracts predict subsequent inaccurate financial reporting as manifest in restatement of accounting data due to errors or other distortions in reporting financial information.
format Online
Article
Text
id pubmed-8356531
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83565312023-05-01 PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting? Rousseau, Denise M. Beck, Donna Kim, ByeongJo Splenda, Ryan Young, Sarah Campbell Syst Rev PROTOCOL This is the protocol for a Campbell review. The objectives are as follows: One goal of this systematic review is to identify whether incentive terms in CEO contracts predict firm financial performance over time; a second goal is to identify whether incentive terms in CEO contracts predict subsequent inaccurate financial reporting as manifest in restatement of accounting data due to errors or other distortions in reporting financial information. John Wiley and Sons Inc. 2019-12-02 /pmc/articles/PMC8356531/ /pubmed/37131856 http://dx.doi.org/10.1002/cl2.1064 Text en © 2019 The Authors. Campbell Systematic Reviews published by John Wiley & Sons Ltd on behalf of The Campbell Collaboration https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle PROTOCOL
Rousseau, Denise M.
Beck, Donna
Kim, ByeongJo
Splenda, Ryan
Young, Sarah
PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title_full PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title_fullStr PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title_full_unstemmed PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title_short PROTOCOL: Does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
title_sort protocol: does executive compensation predict publicly traded firms’ financial performance or inaccurate financial reporting?
topic PROTOCOL
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356531/
https://www.ncbi.nlm.nih.gov/pubmed/37131856
http://dx.doi.org/10.1002/cl2.1064
work_keys_str_mv AT rousseaudenisem protocoldoesexecutivecompensationpredictpubliclytradedfirmsfinancialperformanceorinaccuratefinancialreporting
AT beckdonna protocoldoesexecutivecompensationpredictpubliclytradedfirmsfinancialperformanceorinaccuratefinancialreporting
AT kimbyeongjo protocoldoesexecutivecompensationpredictpubliclytradedfirmsfinancialperformanceorinaccuratefinancialreporting
AT splendaryan protocoldoesexecutivecompensationpredictpubliclytradedfirmsfinancialperformanceorinaccuratefinancialreporting
AT youngsarah protocoldoesexecutivecompensationpredictpubliclytradedfirmsfinancialperformanceorinaccuratefinancialreporting

Ejemplares similares